Primecap Management Co. CA trimmed its stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 12.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,382,081 shares of the company's stock after selling 195,699 shares during the period. Primecap Management Co. CA owned about 0.20% of Corteva worth $78,723,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Los Angeles Capital Management LLC acquired a new stake in Corteva in the third quarter valued at approximately $205,000. Thrivent Financial for Lutherans grew its holdings in Corteva by 16.1% in the third quarter. Thrivent Financial for Lutherans now owns 1,025,266 shares of the company's stock valued at $60,275,000 after purchasing an additional 141,898 shares during the period. Quest Partners LLC acquired a new stake in Corteva in the third quarter valued at approximately $587,000. Pathstone Holdings LLC grew its holdings in Corteva by 3.0% in the third quarter. Pathstone Holdings LLC now owns 98,919 shares of the company's stock valued at $5,815,000 after purchasing an additional 2,846 shares during the period. Finally, Prospera Financial Services Inc grew its holdings in Corteva by 3.5% in the third quarter. Prospera Financial Services Inc now owns 6,687 shares of the company's stock valued at $393,000 after purchasing an additional 226 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, insider Brian Titus sold 26,560 shares of the stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the transaction, the insider now owns 11,347 shares of the company's stock, valued at approximately $723,257.78. This represents a 70.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.20% of the stock is owned by corporate insiders.
Corteva Trading Down 0.2 %
NYSE:CTVA traded down $0.13 on Friday, reaching $61.70. The company's stock had a trading volume of 6,880,464 shares, compared to its average volume of 3,045,028. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The firm has a market cap of $42.30 billion, a price-to-earnings ratio of 47.83, a price-to-earnings-growth ratio of 1.68 and a beta of 0.79. The stock has a 50 day moving average price of $62.44 and a 200 day moving average price of $59.84.
Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. On average, equities analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.
Corteva Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were issued a $0.17 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.10%. Corteva's dividend payout ratio is presently 52.71%.
Analyst Ratings Changes
CTVA has been the topic of several research analyst reports. Citigroup raised their price objective on Corteva from $69.00 to $74.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. The Goldman Sachs Group began coverage on Corteva in a research note on Thursday, March 13th. They issued a "buy" rating and a $71.00 price target on the stock. Barclays lifted their price target on Corteva from $62.00 to $64.00 and gave the stock an "equal weight" rating in a research note on Tuesday, January 21st. Royal Bank of Canada lifted their price target on Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a research note on Friday, February 7th. Finally, Oppenheimer lifted their price target on Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a research note on Friday, February 7th. One analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, Corteva has an average rating of "Moderate Buy" and an average price target of $68.00.
View Our Latest Report on Corteva
Corteva Company Profile
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Featured Stories
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
